Aref Al-Kali, M.D.

  1. Hematologist
  2. Oncologist

Departments

Location

  1. Rochester, Minnesota

Languages

ArabicEnglish
  1. Acute myelogenous leukemia
  2. Chronic myelomonocytic leukemia
  3. Large granular lymphocyte disorders
  4. Myelodysplastic syndromes
  5. Myeloproliferative disorders
  • Myelodysplastic syndromes
  • Acute myeloid leukemia
  • Chronic myelomonocytic leukemia
  • Myeloproliferative neoplasms
  • Acute lymphoblastic leukemia
  1. 2010
    Fellow - Leukemia Fellowship Program Director: Jorge Cortes, M.D. Tel: 713-792-7305University of Texas M.D. Anderson Cancer Center
  2. 2009
    Fellow - Hematology/Oncology Fellowship Program Director: Howard Ozer, M.D., Ph.D. Tel: 405-271-4022Oklahoma University
  3. 2006
    Resident - Internal Medicine Resident Program Director: John Politis, M.D. Tel: 330-884-3267Forum Health, Northeastern Ohio Universities College of Medicine
  4. 2005
    Fellow - Tumor Fellowship Program Director: Eric Svenson, M.D. Tel: 330-884-1000Forum Health, Northeastern Ohio Universities College of Medicine
  5. 2000
    MDUniversity of Damascus Medical School

Certifications

  1. 2009
    HematologyAmerican Board of Internal Medicine

Awards and honors

  1. 2017
    Top 30% Excellence in EducationInternal Medicine Residency Program
  2. 2015
    Top 30% Excellence in EducationInternal Medicine Residency Program
  3. 2013
    Top 30% Excellence in EducationInternal Medicine Residency Program
  4. 2012
    Top 30% Excellence in EducationInternal Medicine Residency Program
  5. 2010
    Kimberly Patterson Leukemia Research AwardUniversity of Texas M.D. Anderson Cancer Center
  6. 2009
    Merit AwardAmerican Society of Hematology
  7. 2008
    In-Training Exam >98%American Society of Clinical Oncology
  8. 2004
    Internal Medicine Exam 97%American Board of Internal Medicine
  9. 2000
    Certificate of AppreciationUniversity of Damascus Medical School

Professional memberships

  1. 2021 - present
    WriterAmerican Board of Internal Medicine
  2. 2020 - present
    MemberNCI Experimental Therapeutics Clinical Trial Network (ETCTN)
  3. 2020 - present
    MemberPOA Workgroup, Division of Hematology; POA Workgroup
  4. 2019 - present
    MemberNational Institutes of Health
  5. 2019
    Liaison PhysicianProject Gazelle, Mayo Clinic Projects
  6. 2019 - 2022
    MemberAmerican Society of Hematology
  7. 2018 - present
    Member and ExpertEducation Committee, American Society of Clinical Oncology
  8. 2018 - present
    Co-ChairHematology Absence Request Team
  9. 2016 - present
    Section ChairDivision of Hematology, Department of Internal Medicine
  10. 2016 - present
    ChairMDS/CMML Focus Group
  11. 2015 - 2020
    Program DirectorMyeloid Advanced Fellowship Program, Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester
  12. 2014 - present
    Committee MemberMyelodysplastic Syndromes Committee ,National Comprehensive Cancer Network (NCCN)
  13. 2011 - present
    Committee MemberHematology Inpatient Service Committee, Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester
  14. 2011 - present
    Committee MemberMayo Clinic Scientific Review Committee - A
  15. 2010 - present
    AssociateEuropean Hematology Association
  16. 2010 - present
    AssociateAmerican Association for Cancer Research
  17. 2007 - present
    AssociateSyrian Society of Clinical Oncology
  18. 2006 - 2009
    AssociateAmerican Society of Bone Marrow Transplant
  19. 2006 - present
    AssociateAmerican Society of Hematology
  20. 2006 - present
    AssociateAmerican Society of Clinical Oncology
  21. 2004 - 2006
    LiaisonAmerican College of Physicians
  22. 2004 - 2006
    MemberResident Council, Ohio Chapter, American College of Physicians
  23. 2003 - 2006
    AssociateAmerican College of Physicians
  24. 2003 - present
    AssociateAmerican Medical Association

Publications

Research activities

See a description of research activities.